Category: Infectious Diseases
Global Infectious Diseases
-
Antimicrobial Susceptibility Testing Market by Product (Manual, Automated), Type (Antibacterial, Antifungal), Application (Clinical Diagnostics), Method (ETEST, Disk Diffusion, Agar Diffusion, Genotyping), End User & Region - Global Forecasts to 2027
... is projected to reach USD 4.7 billion by 2027 from USD 3.6 billion in 2022, at a CAGR of 5.5% during the forecast period. The significant growth of the antimicrobial susceptibility testing market is largely ... Read More
-
Infection Surveillance Solutions Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Offering (Software, Services); By Infection Type (Surgical Site Infections (SSI), Blood Stream Infections (BSI), Urinary Tract Infections (UTI)); By End Use (Long Term Care Facilities, Hospitals); By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)
... By End Use (Long Term Care Facilities, Hospitals); By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa) Global Infection Surveillance Solutions Market Size More Than Doubles to Touch USD 1.2 Billion ... Read More
-
Companion Diagnostics Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Product & Service (Assays, Kits & Reagents, Software & Services); By Technology (Polymerase Chain Reaction, Next-generation Sequencing, In-Situ Hybridization, Immunohistochemistry); By Indication (Cancer, Neurological Disorders, Cardiovascular Diseases, Infectious Diseases); By End User (Pharmaceutical & Biopharmaceutical, Reference Laboratories, Contract Research Organizations); By Region (North America, Europe, Asia Pacific (APAC), Latin America, Middle East and Africa (MEA))
... Immunohistochemistry); By Indication (Cancer, Neurological Disorders, Cardiovascular Diseases, Infectious Diseases); By End User (Pharmaceutical & Biopharmaceutical, Reference Laboratories, Contract Research Organizations); By Region (North America, Europe, Asia Pacific (APAC), Latin America, Middle East and Africa ... Read More
-
The Market and Future Potential for Molecular Point of Care (mPOC), 2023
... from novel trend to significant contributor to the market. The instruments sold by Abbott, BioMérieux, Cepheid and increasingly, a host of other companies, are a significant contributor to the IVD POC market. Knowing these markets ... Read More
-
Infection Surveillance Solutions Market by Software (On-Premise, Web-Based), Services (Product Support & Maintenance, Implementation, Training & Consulting), End User (Hospitals, Long-Term Care Facilities), and Region- Global Forecast to 2027
... anticipated to grow from an estimated USD 577 million in 2022 to USD 1,100 million in 2027, at a CAGR of 13.8% during the forecast period. The market has a promising growth potential due to ... Read More
-
Molecular Diagnostic Market by Product (Reagents & Kits, Systems, Software), Test Type (Lab, PoC), Technology (PCR, INAAT, Sequencing, Microarray), Application (Infectious Diseases, Oncology), End User (Hospital, Diagnostic Lab)—Global Forecast to 2030
... Product (Reagents & Kits, Systems, Software), Test Type (Lab, PoC), Technology (PCR, ISH, INAAT, Sequencing, Microarray), Application (Infectious Diseases, Oncology), End User (Hospital, Diagnostic Lab)—Global Forecast to 2030. The molecular diagnostics market is expected to ... Read More
-
Digital PCR Market Forecasts to 2028 – Global Analysis By Product (Instruments, Reagents & Consumables and Other Products), Technology (Droplet Digital PCR, Chip-based Digital PCR and Other Technologies), Indication (Oncology, Infectious Diseases and Other Indications), Application (Oncology Testing, Blood Screening and Other Applications), End User and Geography
... Application (Oncology Testing, Blood Screening and Other Applications), End User and Geography According to Stratistics MRC, the Global Digital PCR Market is accounted for $539.73 million in 2022 and is expected to reach $2149.48 million ... Read More
-
Contract Research Organization (CRO) Services Market by Type (Early phase, Clinical, Lab, Consulting), Therapeutic Area (Oncology, Infectious Disease, Neurology, Immunology, Hematology, Vaccines, Cell & Gene Therapy), End User & Region - Global Forecast to 2028
... The global CRO services market is estimated to grow at a CAGR of 10.7% during the forecast period. Growth in the CRO services market can mainly be attributed to factors such as the increasing investment ... Read More
-
Infectious Diseases In-Vitro Diagnostics Market Intelligence Report - Global Forecast 2023-2030
... CAGR 7.19% during the forecast period. Market Statistics: The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to ... Read More
-
Human Microbiome Market Report 2023-2033
... dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Big Pharma Players Striving To Gain Market Entry Through Collaboration ... Read More
-
Infection Surveillance Solutions Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... reach US$ 1,177.7 Million by 2028, exhibiting a growth rate (CAGR) of 12.1% during 2023-2028. Infection surveillance solutions assist healthcare personnel in collecting, analyzing, and interpreting data about patients who are suffering from different infections. ... Read More
-
Active Pharmaceutical Ingredients Market Size By Therapeutic Category (Oncology, Infectious Diseases, Anti-Diabetics, CNS & Anesthesia, Cardiovascular Diseases Biologics), By Synthesis (Chemical Based API, Biological API, Highly Potent API (HPAPI)), By Contract Outsourcing (CDMO, CMO), By Application (Humans, Veterinary), By Drug (Prescription, OTC), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2023 - 2032
... Application (Humans, Veterinary), By Drug (Prescription, OTC), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2023 - 2032 Global Active Pharmaceutical Ingredients Market is poised to grow significantly between 2023 and ... Read More
-
Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections - Drugs In Development, 2022, provides an overview of the Vancomycin-Resistant Staphylococcus aureus (VRSA) ... Read More
-
Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections - Drugs In Development, 2022, provides an overview ... Read More
-
Toxoplasmosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Direct's latest Pharmaceutical and Healthcare disease pipeline guide Toxoplasmosis - Drugs In Development, 2022, provides an overview of the Toxoplasmosis (Infectious Disease) pipeline landscape. Toxoplasmosis is a disease that results from infection with the Toxoplasma ... Read More
-
Zika Virus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Zika Virus Infections - Drugs In Development, 2022, provides an overview of the Zika Virus Infections (Infectious Disease) pipeline landscape. Zika virus infection ... Read More
-
Poliomyelitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Direct's latest Pharmaceutical and Healthcare disease pipeline guide Poliomyelitis - Drugs In Development, 2022, provides an overview of the Poliomyelitis (Infectious Disease) pipeline landscape. Polio is a highly infectious disease caused by a virus. It ... Read More
-
Middle East Respiratory Syndrome (MERS) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Middle East Respiratory Syndrome (MERS) - Drugs In Development, 2022, provides an overview of the Middle East Respiratory Syndrome ... Read More
-
Global Pneumonia Therapeutics Market Size study & Forecast, by Therapeutics (Prevention Vaccines and Treatment Drugs), by Distribution Channel (Hospitals, Pharmaceutical Stores, and Others), and by Age Group (Pediatric, Adult, and Geriatric) and Regional Analysis, 2022-2029
... Global Pneumonia Therapeutics Market is valued approximately USD 13.24 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 8.5% over the forecast period 2022-2029. Pneumonia is a type ... Read More
-
Global Immunoassays Market Size, Segments, Outlook, and Revenue Forecast 2022-2028 by Product Type (Reagents & Kits, Analyzers/Instruments, and Software & Services), Application (Cardiology, Oncology, Autoimmune Diseases, Infectious Diseases, and Others), Technology (Radio immunoassay (RIA), Enzyme Immunoassays (EIA) or Enzyme-Linked Immunosorbent Assays (ELISA), Fluoro immunoassay (FIA), Chemiluminescence Immunoassay(CLIA) and Others), By End User (Hospitals & Clinics, Clinical Laboratories, Pharmaceuticals & Biotech Companies, Blood Banks, Academic Research Centers, and Others) and Regions (North America, Asia Pacific, Europe, Latin America, Middle East and Africa)
... Immunoassays (EIA) or Enzyme-Linked Immunosorbent Assays (ELISA), Fluoro immunoassay (FIA), Chemiluminescence Immunoassay(CLIA) and Others), By End User (Hospitals & Clinics, Clinical Laboratories, Pharmaceuticals & Biotech Companies, Blood Banks, Academic Research Centers, and Others) and Regions ... Read More
-
Global Pediatric Vaccines Market By Type (Monovalent, Multivalent), By Technology (Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Subunit, Recombinant, Polysaccharide, and Conjugate Vaccines), By Indication (Varicella, Diphtheria, Pertussis and Tetanus, Influenza, Human Papilloma Virus, Measles, Mumps and Rubella, Meningococcal Disease, Pneumococcal Disease, Polio, Rotavirus, Other Indications): Global Opportunity Analysis and Industry Forecast, 2021-2031
... Mumps and Rubella, Meningococcal Disease, Pneumococcal Disease, Polio, Rotavirus, Other Indications): Global Opportunity Analysis and Industry Forecast, 2021-2031 The global pediatric vaccine market accounted for $2,1371.73 million in 2021, and is expected to reach $ ... Read More
-
Global Flu Vaccine Market - 2022-2029
... during the forecast period (2022-2029). The flu vaccine is inactivated, indicating that it includes the killed influenza virus, or a recombinant vaccine, implying that it was made without exploiting virus particles. Flue vaccination is safe ... Read More
-
Patient Recruitment and Retention Services Market (3rd Edition), 2022-2035
... these trials are prone to delays, and can even fail altogether, they impose an immense financial pressure on sponsors. Studies suggest that around 40% of the total investment made for the development of a drug ... Read More
-
Global Vaccines Market - 2022-2029
... the forecast period (2022-2029). A vaccine is a type of medicine that trains the body’s immune system to fight diseases it has not come into contact with before. Vaccines are developed to prevent disease; when ... Read More
-
Global Clinical Trial Outsourcing Market By Clinical Trial Phase (Phase 0, Phase 1, Phase 2, Phase 3, Phase 4), By Therapeutic Area (Oncology, Hematology, Central Nervous System, Cardiovascular/Metabolic, Respiratory, Infectious Diseases, Immunology, Rare Diseases, Medical Devices, Others), By End User (Biotechnology & Pharmaceutical Companies, Medical Device Companies, Academic & Research Institutions) and By Region, Competition Forecast and Opportunities, 2027
... Devices, Others), By End User (Biotechnology & Pharmaceutical Companies, Medical Device Companies, Academic & Research Institutions) and By Region, Competition Forecast and Opportunities, 2027 Global clinical trial outsourcing market is anticipated to register robust growth ... Read More
Research Assistance
